Fecal Amino Acid Analysis Can Discriminate De Novo Treatment-Naïve Pediatric Inflammatory Bowel Disease From Controls.

MLA

Bosch, Sofie, et al. “Fecal Amino Acid Analysis Can Discriminate De Novo Treatment-Naïve Pediatric Inflammatory Bowel Disease From Controls.” Journal of Pediatric Gastroenterology and Nutrition, vol. 66, no. 5, May 2018, pp. 773–78. EBSCOhost, https://doi.org/10.1097/MPG.0000000000001812.

APA

Bosch, S., Struys, E. A., van Gaal, N., Bakkali, A., Jansen, E. W., Diederen, K., Benninga, M. A., Mulder, C. J., de Boer, N. K. H., & de Meij, T. G. J. (2018). Fecal Amino Acid Analysis Can Discriminate De Novo Treatment-Naïve Pediatric Inflammatory Bowel Disease From Controls. Journal of Pediatric Gastroenterology and Nutrition, 66(5), 773–778. https://doi.org/10.1097/MPG.0000000000001812

Chicago

Bosch, Sofie, Eduard A Struys, Nora van Gaal, Abdellatif Bakkali, Erwin W Jansen, Kay Diederen, Marc A Benninga, Chris J Mulder, Nanne K H de Boer, and Tim G J de Meij. 2018. “Fecal Amino Acid Analysis Can Discriminate De Novo Treatment-Naïve Pediatric Inflammatory Bowel Disease From Controls.” Journal of Pediatric Gastroenterology and Nutrition 66 (5): 773–78. doi:10.1097/MPG.0000000000001812.